Drug Trial Radar · NCT00629278
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
Last checked: Nov 19, 2026Latest source record: Aug 7, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,500
Planned (sponsor's estimate)
Start
Dec 2007
Primary completion
Dec 2010
Sponsor
- Lead sponsor
- Azienda Ospedaliero-Universitaria di ModenaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known which regimen of combination chemotherapy given together with trastuzumab is most effective in treating breast cancer. PURPOSE: This randomized phase III trial is comparing two different regimens of combination chemotherapy given together with trastuzumab to see how well they work in treating women with HER2-positive stage I, stage II, or stage III breast cancer.
Conditions
- Breast Cancer
Interventions
trastuzumabBiological
aromatase inhibition therapyDrug
cyclophosphamideDrug
docetaxelDrug
doxorubicin hydrochlorideDrug
epirubicin hydrochlorideDrug
fluorouracilDrug
paclitaxelDrug
releasing hormone agonist therapyDrug
tamoxifen citrateDrug
adjuvant therapyProcedure
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free survival
- Overall survival
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Ospedale Santa Croce
Cuneo, Italy · Recruiting
Ospedale Civile di Ivrea
Ivrea, Italy · Recruiting
Azienda Ospedaliera - Universitaria di Modena
Modena, Italy · Recruiting
Piacenza Hospital
Piacenza, Italy · Recruiting
Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino
Turin, Italy · Recruiting
Ospedal San Andrea
Vercelli, Italy · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.